The "entrenched, dependent bureaucrats" do not have a personal stake in the amyloid thesis. Their job descriptions are not going to say "approve amyloid applications." Maybe the politicals do, and certainly BP has, but perhaps even they are starting to let it go.
Market Data 
Markets 
AI
